Cell2in, Inc.

USPTO Granted Patents = 5

EPO Patents = 2

Forward Citations = 4

Loading Chart...

12 inventors (with patents filed for the assignee):

Heun Soo Kang (5 out of 5 patents)

Hye Mi Kim (3 out of 8 patents)

Ji Eun Song (3 out of 4 patents)

4. Ki Hang Choi (3 out of 3 patents)

5. Myung Jin Kim (2 out of 7 patents)

6. Yong Hwan Kim (2 out of 113 patents)

7. In-Gyu Kim (2 out of 2 patents)

8. Gwang Mo Yang (2 out of 2 patents)

9. Ji Woong Shin (2 out of 3 patents)

10. Eui Man Jeong (2 out of 2 patents)

11. Hye Won Kang (2 out of 2 patents)

12. Myoung Jin Kim (1 out of 4 patents)

5 patents: Sort by Forward Citations

1. 11841369 - Method for improving quality of therapeutic cell through real-time glutathione measurement (2023-12-12),

2. 11499978 - Method for measuring quality of therapeutic cell through real-time glutathione measurement (2022-11-15),

3. 11472825 - Real-time fluorescence imaging sensor for measuring glutathione in organelle and preparation method therefor (2022-10-18),

4. 10620215 - Real-time imaging sensor for measuring cellular thiol level (2020-04-14),

5. 10215757 - Real-time imaging sensor for measuring cellular thiol level (2019-02-26),

Cell2in, Inc. is a cutting-edge biotechnology company focused on developing innovative cell therapy solutions for various medical conditions. With a team of leading scientists and industry experts, Cell2in is dedicated to advancing the field of regenerative medicine through the use of stem cells and biologics. Our mission is to provide patients with safe and effective treatments to improve their quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#90 in

#1,791 in South Korea

KR